Specialist NHS care provider One Health Group has made an impact in its first full year as an AIM-listed company, reporting revenue and EBITDA ahead of market expectations in a trading statement released on Monday.
The group delivered double-digit growth across every key metric, with revenue risinh 13% to £32.0m for the year to March 2026, comfortably ahead of the £29.4m consensus.
Underlying EBITDA is also said to have surpassed the £2.3m market consensus.
Growth was driven by new NHS patient referrals, which climbed 11% to 18,931 as consultations jumped 20% to over 50,700. Surgical procedures rose 15% to 8,113.
One Health provides NHS care for patients referred for treatment in Orthopaedics, Spine, General Surgery, Gynaecology and Urology, operating from 40 of their locations across the UK.
The company expanded its consultant base by 10% to 88, opened three new outreach clinics, bringing the total to 40, and increased its surgical operating facilities by 40%, from 10 to 14.
Construction of One Health’s first purpose-built surgical hub in Scunthorpe is underway, on track for delivery within a year and within the £8m to £9m budget. The company says the hub is central to the company’s strategy of building owned capacity in underserved areas with high NHS demand. Management said further locations are being assessed for future development.
Adam Binns, Chief Executive Officer, said: “We are delighted to deliver a strong year end trading update ahead of market expectations for our first full year following our AIM listing and that construction of our first surgical hub commenced during this period.
“NHS national waiting lists remain very high, despite continued NHS efforts and recent modest reductions, and we are proud that One Health remains well-positioned to continue to reduce pressure on the NHS by providing free high-quality care across underserved areas.”
The trading update was warmly received by the market, and One Health shares were trading 4% higher at the time of writing.